Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.07
-0.05 (-0.38%)
Mar 9, 2026, 1:35 PM EDT - Market open
Wave Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 42.73 | 108.3 | 113.31 | 3.65 | 40.96 | Upgrade
|
| Revenue Growth (YoY) | -60.55% | -4.42% | 3005.10% | -91.09% | 104.03% | Upgrade
|
| Cost of Revenue | 182.78 | 159.68 | 130.01 | 115.86 | 121.88 | Upgrade
|
| Gross Profit | -140.05 | -51.38 | -16.7 | -112.21 | -80.91 | Upgrade
|
| Selling, General & Admin | 75.33 | 59.02 | 51.29 | 50.51 | 46.11 | Upgrade
|
| Operating Expenses | 75.33 | 59.02 | 51.29 | 50.51 | 46.11 | Upgrade
|
| Operating Income | -215.38 | -110.4 | -68 | -162.72 | -127.02 | Upgrade
|
| Interest & Investment Income | 10.48 | 10.16 | 7.93 | 1.57 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.53 | 3.23 | 1.88 | 0.01 | 4.54 | Upgrade
|
| Pretax Income | -204.38 | -97.01 | -58.19 | -161.14 | -122.45 | Upgrade
|
| Income Tax Expense | - | - | -0.68 | 0.68 | -0.2 | Upgrade
|
| Net Income | -204.38 | -97.01 | -57.51 | -161.82 | -122.25 | Upgrade
|
| Net Income to Common | -204.38 | -97.01 | -57.51 | -161.82 | -122.25 | Upgrade
|
| Shares Outstanding (Basic) | 169 | 138 | 106 | 79 | 52 | Upgrade
|
| Shares Outstanding (Diluted) | 169 | 138 | 106 | 79 | 52 | Upgrade
|
| Shares Change (YoY) | 21.96% | 30.33% | 34.55% | 52.16% | 32.12% | Upgrade
|
| EPS (Basic) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | Upgrade
|
| EPS (Diluted) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | Upgrade
|
| Free Cash Flow | -188.21 | -151.96 | -20.55 | -129.14 | -89.55 | Upgrade
|
| Free Cash Flow Per Share | -1.12 | -1.10 | -0.19 | -1.64 | -1.73 | Upgrade
|
| Gross Margin | - | -47.44% | -14.74% | - | -197.52% | Upgrade
|
| Operating Margin | -504.09% | -101.94% | -60.01% | -4459.30% | -310.07% | Upgrade
|
| Profit Margin | -478.34% | -89.57% | -50.76% | -4434.72% | -298.42% | Upgrade
|
| Free Cash Flow Margin | -440.50% | -140.31% | -18.13% | -3539.11% | -218.61% | Upgrade
|
| EBITDA | -211.94 | -106.51 | -63 | -156.15 | -119.53 | Upgrade
|
| EBITDA Margin | - | -98.34% | -55.60% | - | -291.80% | Upgrade
|
| D&A For EBITDA | 3.44 | 3.9 | 5 | 6.57 | 7.48 | Upgrade
|
| EBIT | -215.38 | -110.4 | -68 | -162.72 | -127.02 | Upgrade
|
| EBIT Margin | - | -101.94% | -60.01% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.